Form 4: Roivant Sciences Director Ilan Oren Receives Stock and Option Awards

Director Ilan Oren received an annual award of restricted stock units and stock options from Roivant Sciences Ltd.

Summary

• Ilan Oren, a director of Roivant Sciences Ltd., received an annual award of 16,406 restricted stock units (RSUs) and 27,894 stock options on September 10, 2024.
• The RSUs and stock options were granted pursuant to the company's 2021 Equity Incentive Plan and Non-Employee Director Compensation Policy.
• The RSUs will vest 100% on September 10, 2025, subject to continuous service through that date.
• The stock options, with an exercise price of $12.19, will also vest and become exercisable 100% on September 10, 2025, subject to continuous service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects standard compensation practices for directors, aligning their interests with shareholders. There are no immediate negative implications.

Positives

• The grant of RSUs and stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Risks

• The value of the RSUs and stock options is dependent on the future performance of Roivant Sciences' stock.
• If the director ceases to provide continuous service, the unvested RSUs and stock options will be forfeited.

Future Outlook

The document does not contain any specific forward-looking statements beyond the vesting schedule of the granted securities.

Industry Context

Granting stock options and restricted stock units to directors is a common practice in the pharmaceutical industry to align their interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Director compensation packages, including stock options and RSUs, are common across the pharmaceutical industry.
• Companies like Pfizer, Johnson & Johnson, and Novartis also utilize equity-based compensation to incentivize their directors.
• The specific amounts and vesting schedules vary based on company size, performance, and individual contributions.

Stakeholder Impact

• Shareholders: Aligns director's interests with shareholder value.
• Employees: May have a minor positive impact on morale as it shows the company is investing in its leadership.
• Director: Provides additional compensation and incentive for performance.

Key Dates